Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells

Chun-Qi Li1, Min Young Kim, Luiz C Godoy

  • 1Department of Biological Engineering and Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Insights

Nitric oxide (*NO) activates the Nrf2-Keap1 pathway, leading to nuclear Nrf2 accumulation and protective gene expression in colon cancer cells. This signaling mitigates *NO-induced apoptosis, enhancing cellular resistance.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Research

Background:

  • The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is a master regulator of cellular defense against oxidative stress.
  • Nitric oxide (*NO) is a signaling molecule with complex roles in cell physiology and pathology, including cancer.
  • The Nrf2-Keap1 (Kelch-like ECH-associated protein 1) pathway is a critical cellular defense mechanism.

Purpose of the Study:

  • To characterize nitric oxide (*NO)-induced Nrf2-Keap1 signaling in human colon cancer HCT116 cells.
  • To investigate the role of this pathway in counteracting *NO-induced apoptosis.
  • To elucidate the molecular mechanisms underlying *NO-mediated Nrf2 activation.

Main Methods:

  • Characterization of Nrf2 localization and transcriptional activity in response to *NO.
  • Analysis of Nrf2-dependent gene expression (HO-1, NQO1, GCL).
  • Investigation of Keap1 modification, specifically (S)-nitrosation, and its effect on Nrf2-Keap1 interaction.

Main Results:

  • *NO induced rapid nuclear accumulation of Nrf2, leading to transcriptional activation of antioxidant genes like HO-1, NQO1, and GCL.
  • (S)-nitrosation of Keap1 was proposed to facilitate Nrf2 dissociation from Keap1, promoting Nrf2 nuclear translocation.
  • Induction of Nrf2-dependent genes preceded caspase 3 activation, indicating a protective response before the onset of apoptosis.

Conclusions:

  • The Nrf2-Keap1 signaling pathway is activated by *NO in HCT116 cells, mediating protective cellular responses.
  • This pathway mitigates *NO-induced cellular damage and contributes to the relative resistance of HCT116 cells to *NO-induced cytotoxicity.
  • Understanding this mechanism offers potential therapeutic insights for colon cancer treatment.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...